Candel Therapeutics, Inc.CADLNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank33
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
-44.63%
↓ 45% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-30.89%
Historical baseline
PeriodValue
2025-44.63%
202413.08%
2023-10.57%
2022-34.97%
2021-86.29%
2020-52.82%
20190.00%